Vice President Kamala Harris held a discussion in her ceremonial office about the fight for reproductive rights and the recent Supreme Court decision in Dobbs v. Jackson Women's Health Organization. The Vice President expressed concern over attempts to restrict people's ability to make decisions about their own bodies, particularly through attacks on access to medication, such as mifepristone, used for medication abortion. She highlighted that mifepristone is FDA approved and has undergone a rigorous review process. The Vice President also criticized attempts to undermine the FDA's authority in determining the safety and efficacy of medications. She emphasized the importance of protecting women's rights and the overall public health system. The Vice President concluded by reaffirming the administration's commitment to upholding reproductive rights and ensuring freedom and liberty for all individuals in the country.